Zacks Investment Research Lowers Voyager Therapeutics Inc. (VYGR) to Hold

Zacks Investment Research downgraded shares of Voyager Therapeutics ... s disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington’s disease ...
News Type: